<DOC>
	<DOCNO>NCT00348582</DOCNO>
	<brief_summary>The purpose study compare clinical outcome , safety efficacy patient randomize receive either ketorolac nepafanac follow cataract surgery .</brief_summary>
	<brief_title>Acular LS vs. Nevanac Post op Inflammation Following Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<criteria>· Male female &gt; 18 year age schedule undergo cataract surgery Must good general health . Patients systemic disease enrol ocular manifestation disease ( ie diabetic normal retinal exam ) Ability provide inform consent likely complete study visit · Known contraindication study medication component Uncontrolled systemic disease Required use ocular medication study medication study Abnormal preoperative OCTs obtainable Diabetic patient Use oral NSAIDS Patients ocular disease ( macula degeneration , glaucoma , corneal disease ) reduce potential visual rehabilitation ( patient ocular disease preclude achievement 20/20 visual outcome may include ) ..</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>